{"id":"https://openalex.org/W2067140702","doi":"https://doi.org/10.1517/14728214.11.1.91","title":"Emerging pharmacological strategies in the fight against cocaine addiction","display_name":"Emerging pharmacological strategies in the fight against cocaine addiction","alternate_titles":[],"publication_year":2006,"publication_date":"2006-02-27","ids":{"openalex":"https://openalex.org/W2067140702","doi":"https://doi.org/10.1517/14728214.11.1.91","mag":"2067140702","pmid":"https://pubmed.ncbi.nlm.nih.gov/16503828"},"language":"en","primary_location":{"id":"doi:10.1517/14728214.11.1.91","doi":"https://doi.org/10.1517/14728214.11.1.91","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14728214.11.1.91","pdf_url":null,"source":{"id":"https://openalex.org/S66445379","display_name":"Expert Opinion on Emerging Drugs","issn_l":"1472-8214","issn":["1472-8214","1744-7623"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Emerging Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2067140702"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052654379","display_name":"Mehmet Sofuoglu","orcid":"https://orcid.org/0000-0002-5401-4681","observed_orcids":["https://orcid.org/0000-0002-5401-4681"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]},{"id":"https://openalex.org/I4210086971","display_name":"VA Connecticut Healthcare System","ror":"https://ror.org/000rgm762","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210086971","https://openalex.org/I4210095851"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mehmet Sofuoglu","raw_affiliation_strings":["Department of Psychiatry, VA Connecticut Healthcare System, Yale University, School of Medicine, West Haven, CT 06516, USA. Mehmet.Sofuoglu@yale.edu","Associate Professor of Psychiatry, Yale University, School of Medicine, Department of Psychiatry and VA Connecticut Healthcare System, 950 Campbell Ave., Bldg. 36/116A4, West Haven, CT 06516, USA. Mehmet.Sofuoglu@yale.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, VA Connecticut Healthcare System, Yale University, School of Medicine, West Haven, CT 06516, USA. Mehmet.Sofuoglu@yale.edu","institution_ids":["https://openalex.org/I32971472","https://openalex.org/I4210086971"]},{"raw_affiliation_string":"Associate Professor of Psychiatry, Yale University, School of Medicine, Department of Psychiatry and VA Connecticut Healthcare System, 950 Campbell Ave., Bldg. 36/116A4, West Haven, CT 06516, USA. Mehmet.Sofuoglu@yale.edu","institution_ids":["https://openalex.org/I32971472","https://openalex.org/I4210086971"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071214414","display_name":"Thomas R. Kosten","orcid":"https://orcid.org/0000-0003-1505-555X","observed_orcids":["https://orcid.org/0000-0003-1505-555X"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]},{"id":"https://openalex.org/I4210086971","display_name":"VA Connecticut Healthcare System","ror":"https://ror.org/000rgm762","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210086971","https://openalex.org/I4210095851"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas R Kosten","raw_affiliation_strings":["Professor of Psychiatry, Yale University, School of Medicine, Department of Psychiatry and VA Connecticut Healthcare System, 950 Campbell Ave., Bldg. 36/116A4, West Haven, CT 06516, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Professor of Psychiatry, Yale University, School of Medicine, Department of Psychiatry and VA Connecticut Healthcare System, 950 Campbell Ave., Bldg. 36/116A4, West Haven, CT 06516, USA","institution_ids":["https://openalex.org/I32971472","https://openalex.org/I4210086971"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.8916,"has_fulltext":false,"cited_by_count":108,"citation_normalized_percentile":{"value":0.85311573,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"11","issue":"1","first_page":"91","last_page":"98"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.7778000235557556,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.7778000235557556,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.20010000467300415,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cocaine-dependence","display_name":"cocaine dependence","score":1.0},{"id":"https://openalex.org/keywords/drug-therapy","display_name":"pharmacotherapy","score":0.9369999766349792},{"id":"https://openalex.org/keywords/disulfiram","display_name":"disulfiram","score":0.9850000143051147},{"id":"https://openalex.org/keywords/tiagabine","display_name":"tiagabine","score":0.9490000009536743},{"id":"https://openalex.org/keywords/topiramate","display_name":"topiramate","score":1.0},{"id":"https://openalex.org/keywords/propranolol","display_name":"propranolol","score":0.972000002861023},{"id":"https://openalex.org/keywords/modafinil","display_name":"modafinil","score":0.9580000042915344},{"id":"https://openalex.org/keywords/cocaine-vaccine","display_name":"cocaine vaccine","score":0.9409999847412109},{"id":"https://openalex.org/keywords/dopamine","display_name":"dopamine","score":0.4410000145435333},{"id":"https://openalex.org/keywords/gaba","display_name":"GABA","score":0.8370000123977661},{"id":"https://openalex.org/keywords/beta-adrenergic-blockade","display_name":"beta-adrenergic blockade","score":0.925000011920929},{"id":"https://openalex.org/keywords/cocaine-withdrawal","display_name":"cocaine withdrawal","score":0.7799999713897705}],"concepts":[{"id":"https://openalex.org/C2778523461","wikidata":"https://www.wikidata.org/wiki/Q409665","display_name":"Disulfiram","level":2,"score":0.7711046934127808},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7636226415634155},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.7098175287246704},{"id":"https://openalex.org/C2776749334","wikidata":"https://www.wikidata.org/wiki/Q907219","display_name":"Tiagabine","level":4,"score":0.6843552589416504},{"id":"https://openalex.org/C2777683783","wikidata":"https://www.wikidata.org/wiki/Q221174","display_name":"Topiramate","level":3,"score":0.6675300598144531},{"id":"https://openalex.org/C2780714222","wikidata":"https://www.wikidata.org/wiki/Q410441","display_name":"Modafinil","level":2,"score":0.6356903314590454},{"id":"https://openalex.org/C2779796075","wikidata":"https://www.wikidata.org/wiki/Q3743188","display_name":"Cocaine dependence","level":3,"score":0.6230785846710205},{"id":"https://openalex.org/C2780557958","wikidata":"https://www.wikidata.org/wiki/Q211036","display_name":"Stimulant","level":2,"score":0.5655136108398438},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.49998044967651367},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45143067836761475},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.39571988582611084},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.21054112911224365},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.12819203734397888}],"mesh":[{"descriptor_ui":"D000077408","descriptor_name":"Modafinil","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000078308","descriptor_name":"Tiagabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001559","descriptor_name":"Benzhydryl Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D003042","descriptor_name":"Cocaine","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D004221","descriptor_name":"Disulfiram","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004221","descriptor_name":"Disulfiram","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004299","descriptor_name":"Dopamine beta-Hydroxylase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D004299","descriptor_name":"Dopamine beta-Hydroxylase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009557","descriptor_name":"Nipecotic Acids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011433","descriptor_name":"Propranolol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014612","descriptor_name":"Vaccines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015259","descriptor_name":"Dopamine Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015259","descriptor_name":"Dopamine Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018755","descriptor_name":"GABA Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019970","descriptor_name":"Cocaine-Related Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D050485","descriptor_name":"GABA Plasma Membrane Transport Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D058805","descriptor_name":"GABA Uptake Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1517/14728214.11.1.91","doi":"https://doi.org/10.1517/14728214.11.1.91","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14728214.11.1.91","pdf_url":null,"source":{"id":"https://openalex.org/S66445379","display_name":"Expert Opinion on Emerging Drugs","issn_l":"1472-8214","issn":["1472-8214","1744-7623"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Emerging Drugs","raw_type":"journal-article"},{"id":"pmid:16503828","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16503828","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on emerging drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":88,"referenced_works":["https://openalex.org/W119361785","https://openalex.org/W156743619","https://openalex.org/W1646202973","https://openalex.org/W1898440000","https://openalex.org/W1963653828","https://openalex.org/W1966136869","https://openalex.org/W1966157739","https://openalex.org/W1967589215","https://openalex.org/W1971786300","https://openalex.org/W1977634040","https://openalex.org/W1978565655","https://openalex.org/W1978644179","https://openalex.org/W1980350720","https://openalex.org/W1982403843","https://openalex.org/W1985043270","https://openalex.org/W1993161822","https://openalex.org/W1994799682","https://openalex.org/W1996443809","https://openalex.org/W2004142723","https://openalex.org/W2006215870","https://openalex.org/W2012164818","https://openalex.org/W2013779336","https://openalex.org/W2014061405","https://openalex.org/W2017277436","https://openalex.org/W2018303551","https://openalex.org/W2019288562","https://openalex.org/W2026018147","https://openalex.org/W2028857574","https://openalex.org/W2028948292","https://openalex.org/W2030276643","https://openalex.org/W2033705393","https://openalex.org/W2034603498","https://openalex.org/W2038531168","https://openalex.org/W2043914857","https://openalex.org/W2045573797","https://openalex.org/W2049743610","https://openalex.org/W2050506325","https://openalex.org/W2054625192","https://openalex.org/W2055534658","https://openalex.org/W2057263259","https://openalex.org/W2058097697","https://openalex.org/W2060298051","https://openalex.org/W2065384856","https://openalex.org/W2066775856","https://openalex.org/W2067020991","https://openalex.org/W2067795033","https://openalex.org/W2067812968","https://openalex.org/W2069728700","https://openalex.org/W2070354024","https://openalex.org/W2071674869","https://openalex.org/W2075478212","https://openalex.org/W2078043304","https://openalex.org/W2083322751","https://openalex.org/W2087045789","https://openalex.org/W2089176369","https://openalex.org/W2090719035","https://openalex.org/W2091487897","https://openalex.org/W2094275595","https://openalex.org/W2096201943","https://openalex.org/W2099764538","https://openalex.org/W2104314642","https://openalex.org/W2107951162","https://openalex.org/W2108264967","https://openalex.org/W2108370770","https://openalex.org/W2110927923","https://openalex.org/W2111112265","https://openalex.org/W2112332369","https://openalex.org/W2112861803","https://openalex.org/W2114564605","https://openalex.org/W2125757256","https://openalex.org/W2135199958","https://openalex.org/W2136792753","https://openalex.org/W2138741431","https://openalex.org/W2140433233","https://openalex.org/W2155133471","https://openalex.org/W2156122963","https://openalex.org/W2161047816","https://openalex.org/W2314953511","https://openalex.org/W2331368560","https://openalex.org/W2395650694","https://openalex.org/W2415384210","https://openalex.org/W2422989603","https://openalex.org/W2462824401","https://openalex.org/W3107187006","https://openalex.org/W4239785504","https://openalex.org/W4252225602","https://openalex.org/W4254811157","https://openalex.org/W4323254129"],"related_works":["https://openalex.org/W1965023161","https://openalex.org/W2224460125","https://openalex.org/W2011140088","https://openalex.org/W2142363976","https://openalex.org/W2061313765","https://openalex.org/W2004404034","https://openalex.org/W2161817834","https://openalex.org/W2150920348","https://openalex.org/W3198030588","https://openalex.org/W2120331967"],"abstract_inverted_index":{"Cocaine":[0],"addiction":[1],"continues":[2],"to":[3,107],"be":[4,68,108],"an":[5],"important":[6],"public":[7],"health":[8],"problem":[9],"worldwide.":[10],"At":[11],"present,":[12],"there":[13],"are":[14],"no":[15],"proven":[16],"pharmacotherapies":[17],"for":[18,31],"cocaine":[19,32,42,87,91,97],"addiction.":[20],"The":[21],"studies":[22],"reviewed":[23],"here":[24],"revealed":[25],"a":[26,36,45,63,81,90],"number":[27,46],"of":[28,47,96],"emerging":[29],"targets":[30],"pharmacotherapy.":[33],"First,":[34],"disulfiram,":[35],"medication":[37],"with":[38,74,80],"dopaminergic":[39],"effects,":[40],"reduced":[41,86],"use":[43],"in":[44,59,111],"clinical":[48,60,113],"trials.":[49,61,114],"Second,":[50],"GABA":[51],"medications,":[52],"tiagabine":[53],"and":[54],"topiramate,":[55],"were":[56],"found":[57],"promising":[58,104],"Third,":[62],"beta-adrenergic":[64],"blocker,":[65],"propranolol,":[66],"may":[67],"effective":[69],"especially":[70],"among":[71],"cocaine-addicted":[72],"individuals":[73],"high":[75],"withdrawal":[76],"severity.":[77],"Fourth,":[78],"treatment":[79],"stimulant":[82],"medication,":[83],"modafinil,":[84],"has":[85],"use.":[88],"Last,":[89],"vaccine":[92],"that":[93],"slows":[94],"entry":[95],"into":[98],"the":[99],"brain":[100],"holds":[101],"promise.":[102],"These":[103],"findings":[105],"need":[106],"further":[109],"tested":[110],"controlled":[112]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2067140702","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
